Maha Coucha Selected Research

Maha Coucha Research Topics

Disease

7	Inflammation (Inflammations) 01/2022 - 01/2016
6	Ischemia 08/2019 - 03/2015
5	Stroke (Strokes) 05/2015 - 10/2012
4	Hypoxia (Hypoxemia) 08/2019 - 08/2012
4	Ischemic Stroke 08/2014 - 10/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
2	Blindness (Hysterical Blindness) 01/2020 - 01/2019
2	Pathologic Neovascularization 01/2020 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2019 - 03/2018
2	Obesity 06/2017 - 02/2017
2	Vascular Remodeling 11/2014 - 11/2014
1	Cognitive Dysfunction 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Vision Disorders (Hemeralopia) 08/2019
1	Herpes Zoster 01/2019
1	Albuminuria 03/2018
1	Myocardial Infarction 03/2018
1	Insulin Resistance 02/2017
1	Hyperglycemia 08/2014
1	Reperfusion Injury 12/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2013
1	Brain Ischemia (Cerebral Ischemia) 03/2013
1	Vascular System Injuries 03/2013
1	Edema (Dropsy) 03/2013

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 01/2020 - 02/2017
4	Proteins (Proteins, Gene)FDA Link 08/2019 - 12/2013
4	Peroxynitrous Acid (Peroxynitrite)IBA 05/2015 - 08/2012
3	Glucose (Dextrose)FDA LinkGeneric 02/2017 - 03/2015
3	salicylhydroxamic acid (SHAM)IBA 10/2016 - 12/2013
2	Oxygen (Dioxygen)IBA 01/2020 - 10/2016
2	Ephrin-B2 (Ephrin B2)IBA 01/2020 - 01/2019
2	ThioredoxinsIBA 08/2019 - 02/2017
2	InflammasomesIBA 08/2019 - 06/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018 - 06/2017
2	3-nitrotyrosineIBA 10/2016 - 05/2015
2	Endothelin Receptors (Endothelin Receptor)IBA 11/2014 - 10/2012
1	Exenatide (Byetta)FDA Link 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2019
1	Claudin-5IBA 01/2019
1	LM11A-31IBA 01/2019
1	Tight Junction ProteinsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Nerve Growth Factor (NGF)IBA 03/2018
1	Tyrosine (L-Tyrosine)FDA Link 06/2017
1	Butyric Acid (Butanoic Acid)IBA 02/2017
1	Small Interfering RNA (siRNA)IBA 10/2016
1	Actins (F Actin)IBA 10/2016
1	LinagliptinIBA 01/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Caspase 3 (Caspase-3)IBA 05/2015
1	Metformin (Glucophage)FDA LinkGeneric 05/2015
1	Protein Kinases (Protein Kinase)IBA 05/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2015
1	SolutionsIBA 03/2015
1	Bosentan (Tracleer)FDA Link 11/2014
1	azilsartanIBA 11/2014
1	Angiotensin II Type 1 Receptor BlockersIBA 11/2014
1	azilsartan medoxomilIBA 11/2014
1	Blood Glucose (Blood Sugar)IBA 08/2014
1	Minocycline (Cyclops)FDA LinkGeneric 03/2013
1	Matrix Metalloproteinases (MMPs)IBA 03/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	CurcuminIBA 03/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2013
1	Endothelins (Endothelin)IBA 10/2012

Therapy/Procedure

1	Lasers (Laser) 06/2017
1	Glycemic Control 11/2014
1	Thrombolytic Therapy 08/2014
1	Length of Stay 08/2014
1	Therapeutics 03/2013